Anti-inflammatory use may not negatively impact oncologic outcomes following intravesical BCG for high-grade non-muscle-invasive bladder cancer

Nirmish Singla, Ahmed Q. Haddad, Niccolo M. Passoni, Matthew Meissner, Yair Lotan

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Purpose: To evaluate whether anti-inflammatory agents affect outcomes in patients receiving intravesical BCG therapy for high-grade (HG) non-muscle-invasive bladder cancer (NMIBC). Methods: We reviewed the records of 203 patients in a prospective database of HG NMIBC from 2006 to 2012 at a single institution. Patients who had muscle-invasive disease (n = 32), low-grade pathology (n = 4), underwent early cystectomy within 3 months (n = 25), had

Original languageEnglish (US)
Pages (from-to)1-7
Number of pages7
JournalWorld Journal of Urology
DOIs
StateAccepted/In press - May 18 2016

Keywords

  • Anti-inflammatory agents
  • BCG
  • Intravesical therapy
  • Non-muscle-invasive bladder cancer

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Anti-inflammatory use may not negatively impact oncologic outcomes following intravesical BCG for high-grade non-muscle-invasive bladder cancer'. Together they form a unique fingerprint.

Cite this